Table 9

EQ-5D and VAS mean, and change, scores at baseline and follow-up

	Asthma	COPD	Diabetes	Epilepsy	Heart failure	Stroke	Total
EQ-5D York tariff
n	255	177	301	95	137	93	1058
Baseline
Mean	0.83	0.67	0.73	0.76	0.64	0.67	0.73
95% CI	0.80 to 0.86	0.63 to 0.71	0.69 to 0.76	0.71 to 0.82	0.59 to 0.69	0.61 to 0.74	0.71 to 0.75
Follow-up
Mean	0.84	0.67	0.72	0.76	0.64	0.67	0.73
95% CI	0.81 to 0.87	0.63 to 0.71	0.69 to 0.76	0.71 to 0.81	0.59 to 0.69	0.60 to 0.73	0.71 to 0.75
Difference
Mean	0.01	−0.002	−0.003	−0.001	−0.005	−0.008	−0.001
95% CI	−0.004 to 0.015	−0.019 to 0.014	−0.013 to 0.008	−0.021 to 0.018	−0.022 to 0.013	−0.31 to 0.13	−0.007 to 0.045
p Value	NS	NS	NS	NS	NS	NS	NS
EQ-5D VAS
n	248	173	296	91	145	82	1035
Baseline
Mean	73.77	62.29	68.16	71.40	62.20	73.84	68.54
95% CI	71.31 to 76.23	59.31 to 65.27	65.84 to 70.48	67.11 to 75.68	58.93 to 65.47	67.18 to 76.75	67.27 to 69.81
Follow-up
Mean	74.33	62.14	69.76	73.59	58.67	71.96	68.42
95% CI	71.94 to 76.72	59.13 to 65.16	67.53 to 71.99	69.68 to 77.50	55.10 to 62.23	67.18 to 76.75	67.16 to 69.68
Difference
Mean	0.56	−0.15	1.60	2.20	−3.53	−1.88	0.12
95% CI	−1.09 to 2.21	−2.94 to 2.66	−0.19 to 3.39	−0.96 to 5.36	−6.67 to −0.38	−5.12 to 1.37	−0.87 to 1.10
p Value	NS	NS	NS	NS	0.029	NS	NS

COPD, chronic obstructive pulmonary disease, NS, not significant; VAS, visual analogue scale.